Currently, there are 265.65M common shares owned by the public and among those 263.34M shares have been available to trade.
The company’s stock has a 5-day price change of 13.89% and -0.05% over the past three months. ARMK shares are trading 0.88% year to date (YTD), with the 12-month market performance up to 21.69% higher. It has a 12-month low price of $29.82 and touched a high of $42.49 over the same period. ARMK has an average intraday trading volume of 2.18 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 13.98%, 10.18%, and 2.38% respectively.
Institutional ownership of Aramark (NYSE: ARMK) shares accounts for 104.84% of the company’s 265.65M shares outstanding.
It has a market capitalization of $9.98B and a beta (3y monthly) value of 1.22. The stock’s trailing 12-month PE ratio is 29.65, while the earnings-per-share (ttm) stands at $1.27. The company has a PEG of 1.54 and a Quick Ratio of 0.84 with the debt-to-equity ratio at 2.02. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.74% over the week and 4.17% over the month.
Earnings per share for the fiscal year are expected to increase by 24.03%, and 17.29% over the next financial year. EPS should grow at an annualized rate of 19.29% over the next five years, compared to -11.14% over the past 5-year period.
Looking at the support for the ARMK, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on February 24, 2025, with the firm’s price target at $48. RBC Capital Mkts coverage for the Aramark (ARMK) stock in a research note released on September 17, 2024 offered a Outperform rating with a price target of $42.50. Deutsche Bank was of a view on August 07, 2024 that the stock is Buy, while Goldman gave the stock Buy rating on January 17, 2024, issuing a price target of $33. Truist on their part issued Buy rating on January 08, 2024.
